AN INHIBITOR THAT INDUCES RAPID TUMOR REGRESSION BY TARGETING A NEW ESTROGEN RECEPTOR UPREGULATED PATHWAY IN METASTATIC BREAST CANCER

$1,051,641FY2014Department of the ArmyDOD

University Of Illinois

Investigators